Düsseldorf-Jülich Symposium on Neurodegenerative Diseases:
Meeting the challenges of Alzheimer's disease: from basic science to clinical translation
Program
Thursday, October 29, 2015
Welcome
Chair: Dieter Willbold, Heinrich Heine University Düsseldorf and Forschungszentrum Jülich
9:20 Opening address
Anja Steinbeck, President of Heinrich Heine University Düsseldorf, Germany
9:30 Introduction and History
Thomas van Groen, University of Alabama at Birmingham, AL, USA
10:30 break
Session I
Chair: Linda J. van Eldik, University of Kentucky, USA
10:45 Moonlighting functions of the beta-secretase - new insights for current and future therapeutic approaches
Gerhard Multhaup, McGill University, Montreal, QC, Canada
11:45 Alzheimer's disease: moving from symptomatic to protein diagnosis
Philip Scheltens, VU University Medical Center Amsterdam, the Netherlands
Lunch (12:45-13:45)
Session II
Chair: Oliver Bannach, Heinrich Heine University Düsseldorf
13:45 Identification and validation of novel protein biomarkers for FTD
Charlotte Teunissen, VU University Medical Center Amsterdam, the Netherlands
14:45 Non-tubulin functions of the microtubule-associated Tau protein
Marie-Christine Galas, Institut national de la santé et de la recherche médicale, Lille, France
15:45 break
Session III
Chair: Antje Willuweit, Forschungszentrum Jülich
16:00 Transgenic animal models for drug development in Alzheimer´s disease: We succeed in mice and fail in human clinical trials!
Manfred Windisch, NeuroScios GmbH, St. Radegund/Graz, Austria
17:00 Poster session (with food and drinks)
Friday, October 30, 2015
Session IV
Chair: Manfred Windisch, NeuroScios GmbH, St. Radegund/Graz, Austria
9:15 From concussion to dementia: targeting dysregulated brain inflammation
Linda J. van Eldik, University of Kentucky, USA
10:15 Alzheimer's disease: paradigm of pre-clinical success & clinical failure
Fred van Leuven, KU Leuven, Belgium
11:15 break
Chair: Janine Kutzsche
11:30 Posttranslational modification of APP leading to different toxic Abeta- species
Hans-Ulrich Demuth, Fraunhofer Institute, Halle, Germany
Lunch (12:30-13:30)
Session VI
Chair: Inga Kadish, University of Alabama at Birmingham, AL, USA
13:30 Naturally occurring autoantibodies and Alzheimer's disease
Richard Dodel, Philipps-University Marburg, Germany
14:30 Biophysical approaches to probe protein aggregation
Tuomas Knowles, University of Cambridge, UK
15:30 break
Session VII
Chair: Thomas van Groen, University of Alabama at Birmingham, AL, USA
16:00 Alzheimer´s disease pathology and transneuronal degeneration
Thomas Deller, Goethe University, Frankfurt, Germany
17:00 End of symposium
Thomas van Groen, University of Alabama at Birmingham, AL, USA